Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Stem Cell Treatment and Cerebral Palsy: A Systematic Review and Meta-Analysis Publisher Pubmed



Motavaf M1 ; Dehghan S2, 3 ; Ghajarzadeh M4 ; Ebrahimi N5 ; Zali A1 ; Safari S1 ; Mirmosayyeb O6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Functional Neurosurgery Research Center, Shohada Tajrish Neurosurgical Comprehensive Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Stem cell and Regeneration Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Universal Council of Epidemiology (UCE), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran
  5. 5. School of medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Isfahan Neurosciences Research Center, Isfahan University of medical sciences, Isfahan, Iran

Source: Current Stem Cell Research and Therapy Published:2024


Abstract

Objective: We designed this systematic review and meta-analysis to estimate the pooled efficacy and safety profile of different types of stem cells in treating patients with cerebral palsy (CP). Methods: We systematically searched PubMed, Scopus, EMBASE, Web of Science, Google Scholar, and also gray literature, including references of the included studies which were published before November 2021. We extracted data regarding the total number of participants, first author, publication year, country of origin, mean age, cell type, cell dose, cell source, method of transplantation, duration of follow-up, Gross motor function, Ashworth scale, and adverse events. Results: We found 2073 articles by literature search; after deleting duplicates, 1194 remained. Nine articles remained for meta-analysis. The SMD of GMF-66 score (after-before) treatment was 1.5 (95% CI:0.7-2.3) (I2 = 89.9%, P < 0.001). The pooled incidence of Gastrointestinal (GI) complications after transplantation was 21% (95% CI:9-33%) (I2 = 56%, P = 0.08). The pooled incidence of fever after transplantation was 18 % (95% CI:6-30%) (I2 = 87.9%, P = 0.08 < 0.001) Conclusion: The result of this systematic review and meta-analysis show that stem cell therapy in cerebral palsy has neuroprotective properties from anti-inflammatory and anti-apoptotic activities. Stem cell therapy seems to be a promising adjunct to traditional therapies for cerebral palsy patients. © 2024 Bentham Science Publishers.
Related Docs
1. Traumatic Brain Injury and Stem Cell Treatments: A Review of Recent 10 Years Clinical Trials, Clinical Neurology and Neurosurgery (2024)
2. Autologous Hematopoietic Stem-Cell Transplantation in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Neurology and Therapy (2022)
Experts (# of related papers)
Ali Riazi (1)